Gary Ruvkun

Gary Ruvkun

Professor of Genetics, Harvard Medical School
Department of Molecular Biology, Massachusetts General Hospital
Hans-Hermann Schoene Distinguished Investigator
Gary Ruvkun

microRNA and RNA interference mechanisms, neuroendocrine control of detoxification, immunity, metabolism, aging, and microbial diversity

Our lab uses C. elegans molecular genetics and genomics to study miRNA and RNAi pathways as well as mechanisms of aging and microbial surveillance. Using genetic and RNA interference approaches, we have identified genes that positively or negatively regulate RNAi and microRNA pathways.  These genes reveal the trajectory of siRNAs and miRNAs as they target mRNAs, as well as components that may be developed as drug targets to enhance RNAi.  This analysis has revealed subcellular organelles that mediate steps in the small RNA pathways. 

 
Our genetic analysis of C. elegans lifespan revealed a surprising surveillance of conserved core components of cells, such as the ribosome, the mitochondrion, the proteasome, and a coupling to the induction of detoxification and innate immune responses.  We are now dissecting this surveillance system by isolating mutations in C. elegans that fail to recognize deficits in ribosomal, mitochondrial or proteasomal function or fail to induce detoxification responses.   The drug or essential gene inactivations or mutations in the core cellular components inhibit feeding and induce an aversive behavior program. The endocrine state of these aversively stimulated animals may be homologous to the endocrine state of humans who feel unwell. Our genetic suppressors this surveillance pathway is beginning to reveal an endocrinology of feeling ill. The human homologues of the genes we identify promise to explain how humans respond appropriately and inappropriately to drugs or bacteria, or activate drug detoxification and innate immunity pathways in the absence of a triggering drug or bacteria, perhaps inducing a false endocrine state of poisoning or a false perception of infection. Variation in xenobiotic detection and response pathways may be the cause of diseases as diverse as autoimmune disorders and anorexia.
 

Selected Publications:

Soukas, AA, CE Carr, and G Ruvkun. 2013.  Genetic Regulation of C. elegans Lysosome Related Organelle Function.  PloS Genetics, Oct;9(10):e1003908. 

Fischer, SEJ, Q Pan, PC. Breen, Y Qi, Z Shi, C Zhang, TA Montgomery, and G Ruvkun.  2013.  Multiple C. elegans silencing pathways converge to silence duplicated sequences   Genes and Development, 2013 Dec 15;27(24):2678-95.

Garcia, SMDA, Y Tabach, G Lourenço, and G Ruvkun. 2014. Identification of genes in toxicity pathways of trinucleotide repeat RNA in C. elegans toxicity.  Nature Structural and Molecular Biology, 2014 Aug;21(8):712-20.

Liu, Y, PC Breen and G Ruvkun.  2014.  Caenorhabditis elegans pathways that surveil and defend mitochondria.  Nature. 2014 Apr 17;508(7496):406-10.

 

 

 

Contact Information

Simches Research Building, 7th Floor, CPZN-7250
185 Cambridge Street, Boston, MA 02114
p: 617 726-5959

Faculty Alphabetical